Angelalign Technology Reports Strong 2025 Results

on

Global and Chinese Markets Propel Growth

SYDNEY — Angelalign Technology Inc. has announced a significant increase in its 2025 financial performance. The company reported a 48.1% rise in total case volume, reaching 532,400 cases, according to the latest results. Revenue surged by 37.8% to USD 370.3 million, while adjusted net profit climbed by 63.0% to USD 43.8 million.

The company’s CEO, Fox Hu, highlighted the role of clinical excellence and an inclusive culture in achieving these results. “Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence,” said Hu. This approach has been pivotal in the company’s global expansion strategy.

The announcement comes as the clear aligner industry experiences rapid growth. Angelalign has positioned itself strongly in top global cities, building a reputation among premium orthodontists. The company has made substantial investments to provide local services and support.

Expansion and Innovation Drive Success

Angelalign’s innovative products, such as the angelButton™ and A6 Mandibular Advancement solutions, have been well received by clinicians worldwide. The company’s focus on improving patient experiences and solving clinician pain points has reinforced its market presence.

In 2025, the company’s global markets, excluding mainland China, recorded a case increase of 82.1%, reaching 256,200 cases. Revenue in these markets grew by 102.5% to USD 163.0 million, driven by professional recommendations and clinical results.

In China, Angelalign continues to expand its product portfolio, particularly in lower-tier markets, where it has strengthened its leadership despite other brands exiting these regions. The company’s comprehensive support for orthodontists has led to a 26.3% increase in cases, totaling 276,200, with revenue up by 10.1% to USD 207.3 million.

Angelalign’s commitment to innovation and an inclusive corporate culture is expected to support sustained growth. The company plans to continue investing in technical advancements and enhancing global clinical support systems.

Last updated: 30 March 2026, 12:18 pm

Daniel Rolph
Daniel Rolphhttp://melbourne-insider.au/
Daniel Rolph is the editor of Melbourne Insider, covering hospitality, venue openings and events across Melbourne. With over 15 years’ experience in marketing and media, he brings a commercial, newsroom-focused approach to accurate and timely local reporting.
Daniel Rolph
Daniel Rolph is the editor of Melbourne Insider, covering hospitality, venue openings and events across Melbourne. With over 15 years’ experience in marketing and media, he brings a commercial, newsroom-focused approach to accurate and timely local reporting.